Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Maintain Neutral Rating on MidAmerica Apartment Communities with Adjusted Price Targets

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Real Estate Investment Markets and money
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Analyst Vikram Malhotra from Mizuho has decided to keep a Neutral rating on Mid-America Apartment Communities (NYSE: MAA) but has adjusted the price target to $126 from $132. This change comes after a series of price target adjustments by various analysts, with an average hold rating and price target range of $124 to $158 according to Capital IQ. Linda Tsai from Jefferies also joined in on the discussion, lowering the price target to $124.
These updates suggest a cautious approach towards Mid-America Apartment Communities’ stock performance, indicating a shift in sentiment among analysts.

MAA Stock Shows Positive Momentum with 0.96% Increase – Investors Advised to Proceed with Caution

On February 28, 2024, MAA stock showed some positive momentum as it closed the day with a 0.96% increase in its share price. The stock closed at $124.89, which was $1.19 higher than the previous close. Additionally, in after-hours trading, MAA continued to rise, with the stock increasing by $0.43.

Investors should keep an eye on MAA in the coming days to see if the positive momentum continues. It will be important to monitor whether the stock can break through its 200-day moving average and start trending upwards. Additionally, any news or developments related to the company could also impact the stock’s performance.

Overall, while MAA may have shown some positive movement on February 28th, investors should approach the stock with caution and conduct thorough research before making any investment decisions.

MAA Stock Performance Analysis: Revenue Growth but Net Income Decline

On February 28, 2024, MAA stock had mixed performances based on the financial data provided by CNN Money. The total revenue for MAA stood at $2.15 billion for the past year, with a quarterly revenue of $542.25 million. The total revenue increased by 6.37% compared to the previous year but remained flat since the last quarter.

The net income for MAA was reported at $552.58 million for the past year, with a quarterly net income of $160.41 million. The net income decreased by 13.25% since the previous year but saw a significant increase of 44.92% since the last quarter.

The earnings per share (EPS) for MAA were $4.71 for the past year and $1.36 for the last quarter. The EPS decreased by 14.18% compared to the previous year but increased by 45.12% since the last quarter.

Overall, MAA stock showed a mix of positive and negative performances on February 28, 2024. The increase in total revenue since last year indicates growth in the company’s top line, while the decrease in net income and EPS compared to the previous year may raise some concerns among investors. However, the significant increase in net income and EPS since the last quarter could be seen as a positive sign for the company’s financial health in the short term.

Tags: MAA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Assets (2)

Ambarellas Stock Soars After Exceeding Expectations in Q4 FY24

Finance_Banking (2)

Analyst Updates Rating on Array Technologies to Neutral

AI medical laboratory

Crinetics Pharmaceuticals Secures 350 Million in Private Placement Financing

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com